Albert David cash flow

Latest FY26

Cash from operations: −₹7.7cr−₹28.4 cr in FY25
Capital spending: ₹0.0cr−100.0% on FY25
Free cash flow: −₹7.7cr−₹43.3 cr in FY25
Cash from financing: ₹11.9cr+10,708.3% on FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Changes in working capital
Adjustments to reconcile profit — non-cash items						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	—	9.8	7.0	6.8	8.5
	—	2.6	0.4	0.3	0.5
	—	0.0	−3.8	−4.1	−3.3
	—	0.1	−0.2	−0.4	−0.4
	—	3.9	−19.8	−45.6	−3.2
	—	0.1	0.0	0.0	−0.0
	—	−0.0	−0.3	0.0	0.0
	—	−0.6	0.9	−1.5	−0.8
	—	5.6	−20.3	7.1	−11.5
	—	−6.6	1.9	1.0	−5.3
	—	0.0	0.0	−0.4	−0.7
	—	0.0	−0.3	0.0	−0.1
	—	−5.3	−3.6	−0.3	0.1
	—	0.4	1.8	0.0	0.7
	—	0.0	−0.0	0.0	0.0
	—	−5.1	3.6	1.8	1.1
	—	0.0	−4.9	−3.1	−5.3
	—	−3.3	−0.2	−0.6	−0.4
	—	−0.8	−2.7	2.3	0.1
	—	0.0	−0.0	0.4	−4.3
	—	0.0	−4.8	0.5	−0.2
Cash from operating activities
	27.9	0.5	25.2	97.3	50.7
	—	0.7	−45.2	−35.7	−24.5
	—	1.3	−19.9	61.6	26.2
	—	−3.7	0.0	0.0	0.0
	—	0.1	0.0	0.0	0.0
	—	−0.3	0.0	0.0	0.0
	—	5.0	8.5	16.1	15.7
	—	−7.7	−28.4	45.5	10.5
Cash from investing activities
	—	0.0	14.9	10.9	5.2
	—	0.3	0.3	0.0	0.4
	—	0.4	0.0	0.0	0.0
	—	29.1	0.0	0.0	0.0
	—	0.0	0.0	40.9	6.3
	—	13.9	31.0	0.0	6.0
	—	0.0	1.7	0.0	0.0
	—	0.0	1.6	7.7	1.6
	—	0.0	0.0	0.0	4.0
	—	2.0	0.0	5.0	0.0
	—	0.1	0.2	0.4	0.4
	—	4.1	3.4	5.4	2.2
	—	4.0	0.0	0.0	0.0
	—	−4.4	23.3	−33.2	−5.0
Cash from financing activities
	—	18.4	7.9	0.0	0.2
	—	0.0	0.0	1.9	0.0
	—	1.2	1.0	1.0	1.1
	—	2.5	6.5	0.2	0.3
	—	2.9	0.2	5.2	5.1
	—	11.9	0.1	−8.3	−6.4
	—	−0.1	−5.0	4.0	−0.8
	—	0.0	0.0	0.0	0.0
	—	−0.1	−5.0	4.0	−0.8
	—	—	—	5.4	1.4
Reference items
	26.8	5.5	3.0	46.9	44.3
	7.3%	1.6%	0.9%	12.9%	13.0%
	−7.7	−7.7	−43.3	34.6	5.3
	—	8.3	−41.9	31.2	—
	−₹13.42	−₹13.42	−₹75.85	₹60.67	₹9.25
	—	5.12×	−1.65×	0.60×	0.29×
	—	5.0	8.5	16.1	15.7
	—	2.5	6.5	0.2	0.3

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

ALBERTDAVD₹772.00

Albert David Limited

· Pharma & Health

₹ CrorePeersVALIANTLAB HALEOSLABS ZIMLAB MEDICO MEDICAMEQ ANUHPHR AHCL WANBURYMcap ₹441 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation	8.5	6.8	7.0	9.8	—
+ Finance Costs	0.5	0.3	0.4	2.6	—
+ Interest Income	-3.3	-4.1	-3.8	0.0	—
+ Dividend Income	-0.4	-0.4	-0.2	0.1	—
+ Fair Value (Gains) / Losses	-3.2	-45.6	-19.8	3.9	—
+ Unrealised FX (Gain) / Loss	-0.0	0.0	0.0	0.1	—
+ Other Non-cash Items	0.0	0.0	-0.3	-0.0	—
+ Other Reconciling Items	-0.8	-1.5	0.9	-0.6	—
Changes in Working Capital
+ Inventories	-11.5	7.1	-20.3	5.6	—
+ Trade Receivables — Current	-5.3	1.0	1.9	-6.6	—
+ Other Financial Assets — Current	-0.7	-0.4	0.0	0.0	—
+ Other Financial Assets — Non-current	-0.1	0.0	-0.3	0.0	—
+ Other Current Assets	0.1	-0.3	-3.6	-5.3	—
+ Other Non-current Assets	0.7	0.0	1.8	0.4	—
+ Other Bank Balances	0.0	0.0	-0.0	0.0	—
+ Trade Payables — Current	1.1	1.8	3.6	-5.1	—
+ Other Financial Liabilities — Current	-5.3	-3.1	-4.9	0.0	—
+ Other Financial Liabilities — Non-current	-0.4	-0.6	-0.2	-3.3	—
+ Other Current Liabilities	0.1	2.3	-2.7	-0.8	—
+ Provisions — Current	-4.3	0.4	-0.0	0.0	—
+ Provisions — Non-current	-0.2	0.5	-4.8	0.0	—
Cash from Operating Activities
Profit Before Tax (per I/S)	50.7	97.3	25.2	0.5	27.9
+ Total Adjustments (incl. Working Capital)	-24.5	-35.7	-45.2	0.7	—
Cash from Operations (pre-tax)	26.2	61.6	-19.9	1.3	—
+ Interest Received — Operating	0.0	0.0	0.0	-3.7	—
+ Dividends Received — Operating	0.0	0.0	0.0	0.1	—
+ Other Inflows / (Outflows) — Operating	0.0	0.0	0.0	-0.3	—
+ Income Taxes Paid	15.7	16.1	8.5	5.0	—
Cash from Operating Activities	10.5	45.5	-28.4	-7.7	—
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)	5.2	10.9	14.9	0.0	—
+ Disp of Fixed Assets	0.4	0.0	0.3	0.3	—
+ Disp of Intangible Assets	0.0	0.0	0.0	0.4	—
+ Acq of Intangibles under Development	0.0	0.0	0.0	29.1	—
+ Acq of Investment Property	6.3	40.9	0.0	0.0	—
+ Disp of Investment Property	6.0	0.0	31.0	13.9	—
+ Disp of Other Long-term Assets	0.0	0.0	1.7	0.0	—
+ Sale of Investments (Equity / Debt)	1.6	7.7	1.6	0.0	—
+ Loans & Advances Made	4.0	0.0	0.0	0.0	—
+ Loans & Advances Repaid	0.0	5.0	0.0	2.0	—
+ Dividends Received — Investing	0.4	0.4	0.2	0.1	—
+ Interest Received — Investing	2.2	5.4	3.4	4.1	—
+ Other Inflows / (Outflows) — Investing	0.0	0.0	0.0	4.0	—
Cash from Investing Activities	-5.0	-33.2	23.3	-4.4	—
Cash from Financing Activities
+ Proceeds from Borrowings	0.2	0.0	7.9	18.4	—
+ Repayment of Borrowings	0.0	1.9	0.0	0.0	—
+ Payment of Lease Liabilities	1.1	1.0	1.0	1.2	—
+ Interest Paid	0.3	0.2	6.5	2.5	—
+ Dividends Paid	5.1	5.2	0.2	2.9	—
Cash from Financing Activities	-6.4	-8.3	0.1	11.9	—
Net Changes in Cash (pre-FX)	-0.8	4.0	-5.0	-0.1	—
+ Effect of FX Rate Changes on Cash	0.0	0.0	0.0	0.0	—
Net Changes in Cash	-0.8	4.0	-5.0	-0.1	—
Closing Cash	1.4	5.4	—	—	—
Reference Items
EBITDA	44.3	46.9	3.0	5.5	26.8
EBITDA Margin %	12.98	12.93	0.88	1.64	7.34
Free Cash Flow (CFO − Capex)	5.3	34.6	-43.3	-7.7	-7.7
Free Cash Flow to Equity	—	31.2	-41.9	8.3	—
Free Cash Flow per Basic Share	9.25	60.67	-75.85	-13.42	-13.42
Cash Flow to Net Income	0.29	0.60	-1.65	5.12	—
Cash Paid for Taxes	15.7	16.1	8.5	5.0	—
Cash Paid for Interest	0.3	0.2	6.5	2.5	—

As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.